EnLiven Therapeutics

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

• CAChristoph AdamsDirector · Executive Officer
• MAMette AggerDirector
• RBRahul BallalDirector · Executive Officer
• JBJake BauerDirector
• DBDavid BonitaDirector
• MCMark ChinDirector
• HCHelen CollinsExecutive Officer
• BDBarbara DaltonDirector
• MDMika DerynckDirector
• CGCarl GoldfischerDirector
• RGRishi GuptaDirector
• RHRichard HeymanDirector
• BHBenjamin HohlExecutive Officer
• RHRobert HopfnerDirector
• SKSamuel KintzDirector · Executive Officer
• JLJoseph LyssikatosDirector · Executive Officer
• JMJames McArthurDirector · Executive Officer
• DMDavid MottDirector
• SNSara NayeemDirector
• APAnish PatelExecutive Officer
• APAndrew PhillipsDirector

• 11 Apr 2024Lactam (hetero)arylfusedpyrimidine Derivatives As Inhibitors Of ERBB2application
• 07 Nov 2023Fused Tetracyclic Quinazoline Derivatives As Inhibitors Of ERBB2granted
• 24 Aug 2023Alkyne Quinazoline Derivatives As Inhibitors Of ERBB2application
• —Lactam (hetero)arylfusedpyrimidine Derivatives As Inhibitors Of ERBB2application
• —5- And 6-AZAINDOLE Compounds For Inhibition Of Bcr-abl Tyrosine Kinasesapplication
• —7-AZAINDOLE Compounds For Inhibition Of Bcr-abl Tyrosine Kinasesapplication
• —Lactam Quinazoline Derivatives As Inhibitors Of ERBB2application
• —5- And 6-AZAINDOLE Compounds For Inhibition Of Bcr-abl Tyrosine Kinasesapplication
• —Alkyne Quinazoline Derivatives As Inhibitors Of ERBB2application
• —Naphthyridone Compounds For Inhibition Of Bcr-abl Tyrosine Kinasesapplication
• —Alkyne Quinazoline Derivatives As Inhibitors Of ERBB2application
• —Lactam Quinazoline Derivatives As Inhibitors Of ERBB2application

• 07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
• 30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
• 30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
• 29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
• 26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
• 26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.